language Türkçe
Article 2022 · 8 citations

New benzamide derivatives and their nicotinamide/cinnamamide analogs as cholinesterase inhibitors

Koca, Mehmet, Bilginer, Sinan

Abstract

In this study, a total of 18 new benzamide/ nicotinamide/ cinnamamide derivative compounds were designed and synthesized for the first time (except B1 and B5) by conventional and microwave irradiation methods. The chemical structures of the synthesized compounds were characterized by H-1 NMR, C-13 NMR, and HRMS spectra. In vitro acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition effects of the compounds were evaluated to find out new possible drug candidate molecule/s. According to the inhibition results, the IC50 values of the compounds synthesized were in the range of 10.66-83.03 nM towards AChE, while they were in the range of 32.74-66.68 nM towards BuChE. Tacrine was used as the reference drug and its IC50 values were 20.85 nM and 15.66 nM towards AChE and BuChE, respectively. The most active compounds B4 (IC50: 15.42 nM), N4 (IC50: 12.14 nM), and C4 (IC50: 10.67 nM) in each series towards AChE were docked at the binding site of AChE enzyme to explain the inhibitory activities of each series. On the other hand, the compounds B4, N4, and C4 showed satisfactory pharmacokinetic properties via the prediction of ADME profiles. Graphic abstract

Keywords
Benzamide Nicotinamide Cinnamamide Cholinesterase inhibition Molecular docking BIOLOGICAL EVALUATION ALZHEIMERS-DISEASE DOCKING DESIGN ACID 2-BUTENEDIAMIDE METABOLISM TARGET FOODS
WoS Categories
Biochemistry & Molecular Biology Chemistry, Applied Chemistry, Medicinal Chemistry, Multidisciplinary
Sustainable Development Goals
Citation
Journal
MOLECULAR DIVERSITY
Year
2022
Volume
26
Issue
2
Pages
1201-1212
ISSN
1381-1991
eISSN
1573-501X
DOI
10.1007/s11030-021-10249-9
WoS UID
WOS:000665680500002
Open via DOI